Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Gower Publishing

Bristol-Myers Squibb (BMS) building

BMS’ Opdivo defies naysayers with healthy growth

Third quarter sales of the PD1 inhibitor saw a 38% rise

- PMLiVE

Positive trial results for Janssen’s Symtuza boosts its HIV credentials

The STR provided ‘effective’ and ‘durable’ viral suppression

- PMLiVE

Amgen hopes its latest Kyprolis trial hits the mark with regulators

A.R.R.O.W study takes aim at once-weekly dosing regimen in multiple myeloma

- PMLiVE

Aelix Therapeutics appoints Dr Thomas Hecht

He joins the Spanish biotech as chairman of the board of directors

- PMLiVE

RJW & Partners appoints new director

Cathy Beecher joins from ICON

- PMLiVE

BPR Pharma strengthens research team

Vicky Davies joins the UK-based international research agency from Bedrock Healthcare

Executive Insight strengthens UK presence with new partner

David Ewbank joins the firm from McCann Health

- PMLiVE

Redefining the real value within a good value proposition

Successful value propositions

- PMLiVE

Boosting pharma’s metabolic rate

How using more diversity at the top can speed-up change

- PMLiVE

Achieving deep understanding of healthcare customer behaviour

In part one of a series on customer insight and behaviour change, Martine Leroy reveals a behaviour framework for gathering sharp insights used to help brand managers and marketers achieve...

Blue Latitude Health

- PMLiVE

Random42 celebrates at Cannes Corporate 2017

Wins gold dolphin award for Defending LIfe: The Immune Ecosystem

- PMLiVE

Shire’s gene therapy candidate receives orphan drug status in the US

Investigational factor VIII treatment SHP654 is being developed for haemophilia

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links